Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115163772 | 11516377 | 2 | F | 201204 | 20160916 | 20150917 | 20160922 | PER | US-PFIZER INC-2015298199 | PFIZER | 55.00 | YR | F | Y | 72.00000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115163772 | 11516377 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | 2 MG, 1X/DAY | Y | 21110 | 2 | MG | TABLET | QD | ||||||
| 115163772 | 11516377 | 2 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115163772 | 11516377 | 1 | Lymphangioleiomyomatosis |
| 115163772 | 11516377 | 2 | Lung disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115163772 | 11516377 | Diarrhoea | |
| 115163772 | 11516377 | Headache | |
| 115163772 | 11516377 | Mouth ulceration | |
| 115163772 | 11516377 | Oedema peripheral | |
| 115163772 | 11516377 | Post thrombotic syndrome | |
| 115163772 | 11516377 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115163772 | 11516377 | 1 | 201112 | 0 |